Related Experiment Video
Updated: Apr 26, 2026

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
Published on: September 1, 2018
Immunological targeting of cytomegalovirus for glioblastoma therapy
Smita K Nair1, John H Sampson1, Duane A Mitchell2
1Department of Surgery; Duke University Medical Center; Duke Cancer Institute; Durham, NC USA.
Abstract:
Human cytomegalovirus (CMV) is purportedly present in glioblastoma (GBM) while absent from the normal brain, making CMV antigens potentially ideal immunological anti-GBM targets. We recently demonstrated that patient-derived CMV pp65-specific T cells are capable of recognizing and killing autologous GBM tumor cells. This data supports CMV antigen-directed immunotherapies against GBM.
Related Concept Videos
Tumor Immunotherapy
Cytomegalovirus Disease
Targeted Cancer Therapies
There are several types of targeted therapies against...

